Equity Overview
Price & Market Data
Price: $2.91
Daily Change: -$0.05 / 1.72%
Range: $2.85 - $3.01
Market Cap: $88,719,208
Volume: 55,001
Performance Metrics
1 Week: -1.02%
1 Month: -8.78%
3 Months: -20.27%
6 Months: -61.25%
1 Year: -64.43%
YTD: -26.33%
Company Details
Employees: 92
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.